|
|||||
|
|
Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes |
|
| Authors: | Ikeda Keiichi Tojo Katsuyoshi Otsubo Chikara Udagawa Takashi Hosoya Tatsuo Tajima Naoko Nakao Kazuwa Kawamura Masahiro |
| Institution: | aDepartment of Pharmacology (I), Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo 105-8461, Japan bDivision of Diabetes and Endocrinology, Jikei University School of Medicine, Tokyo 105-8461, Japan cDivision of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo 105-8461, Japan dDepartment of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan |
| Abstract: | Urocortin (Ucn) II and III, homologous peptides of Ucn that are specific ligands for corticotropin-releasing hormone (CRH) type 2 receptor (CRH-R2), have recently been identified. The present study was designed to elucidate the effects of Ucn II, which is predominantly expressed in rodent heart, on neonatal rat cardiac myocytes (MCs) and cardiac non-myocytes (NMCs). Ucn II increased the incorporation of 3H]-leucine into MCs, as well as the accumulation of cAMP and the secretion of atrial natriuretic peptide. However, no significant changes were demonstrated in NMCs or an MC/NMC co-culture system. The effects of Ucn II were attenuated by astressin2-B, a specific antagonist of CRH-R2, and/or H89, an inhibitor of protein kinase A (PKA). These results indicate that Ucn II may be another endogenous cardiovascular substance that acts via CRH-R2 and the cAMP-dependent PKA pathway. |
| Keywords: | Urocortin Urocortin II Urocortin III Astressin2-B Corticotropin-releasing hormone receptor Cardiac myocyte |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |